Anger-Góra Natalia, Węgierek-Ciura Katarzyna, Szczygieł Agnieszka, Mierzejewska Jagoda, Pajtasz-Piasecka Elżbieta, Rossowska Joanna
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, Poland.
Oncol Lett. 2021 Aug;22(2):582. doi: 10.3892/ol.2021.12843. Epub 2021 Jun 2.
Myeloid-derived suppressor cells (MDSCs) are potent suppressors of antitumor immunity and their accumulation is often associated with poor prognosis. The aim of the present study was to determine the mechanisms of action of lentiviral vectors encoding short hairpin (sh)RNA against interleukin-10 (IL-10), with particular emphasis on their influence on the activity of tumor-derived MDSCs. Lentiviral vectors encoding shRNA against IL-10 (shIL-10 LVs) were utilized to silence the expression of IL-10 either in MDSCs that were generated from bone marrow cells cultured in the presence of supernatant from MC38 colon carcinoma cells, or in the MC38 murine colon carcinoma environment. Although monocytic MDSCs (M-MDSCs) transduced with shIL-10 LVs exhibited increased suppressor activity, transduction of polymorphonuclear MDSCs (PMN-MDSCs) appeared to reduce their ability to inhibit T lymphocyte functions. Analysis of EGFP expression in MC38 tumors revealed that intratumorally inoculated shIL-10 LVs transduced tumor-infiltrating myeloid cells with the highest efficiency and, led to a decreased IL-10 level in the tumor microenvironment. However, the effect was accompanied by increased influx of PMN-MDSCs into tumors observed both on the 6th and on the 10th day after shIL-10 LV injections. Nevertheless, it was noted that suppressor activity of myeloid cells isolated from tumors was dependent on the efficiency of tumor-derived PMN-MDSC transduction with shIL-10 LVs. The increased percentage of transduced PMN-MDSCs on the 10th day was associated with diminished immunosuppressive activity of tumor-derived myeloid cells and an elevated ratio of cytotoxic T lymphocytes to M-MDSCs. The obtained data indicated that treatment with shIL-10 LVs may result in modulation of the immunosuppressive activity of MC38 colon carcinoma-derived MDSCs.
髓源性抑制细胞(MDSCs)是抗肿瘤免疫的强效抑制剂,其积累通常与不良预后相关。本研究的目的是确定编码针对白细胞介素-10(IL-10)的短发夹(sh)RNA的慢病毒载体的作用机制,特别强调其对肿瘤来源的MDSCs活性的影响。编码针对IL-10的shRNA的慢病毒载体(shIL-10 LVs)用于沉默在MC38结肠癌细胞上清存在下培养的骨髓细胞产生的MDSCs中,或在MC38小鼠结肠癌环境中的IL-10表达。尽管用shIL-10 LVs转导的单核MDSCs(M-MDSCs)表现出增强的抑制活性,但多形核MDSCs(PMN-MDSCs)的转导似乎降低了它们抑制T淋巴细胞功能的能力。对MC38肿瘤中EGFP表达的分析表明,瘤内接种的shIL-10 LVs以最高效率转导肿瘤浸润性髓样细胞,并导致肿瘤微环境中IL-10水平降低。然而,在注射shIL-10 LVs后的第6天和第10天观察到,这种效应伴随着PMN-MDSCs向肿瘤内的流入增加。尽管如此,值得注意的是,从肿瘤中分离的髓样细胞的抑制活性取决于用shIL-10 LVs对肿瘤来源的PMN-MDSC的转导效率。第10天转导的PMN-MDSCs百分比增加与肿瘤来源的髓样细胞免疫抑制活性降低以及细胞毒性T淋巴细胞与M-MDSCs的比例升高有关。获得的数据表明,用shIL-10 LVs治疗可能导致MC38结肠癌来源的MDSCs免疫抑制活性的调节。